Corrigendum to "abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21]
Schizophr Res. 2016 Oct;176(2-3):582.
doi: 10.1016/j.schres.2016.05.025.
Epub 2016 Jun 2.
1 Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
2 Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Department of Education, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
3 MR Advanced Applications, GE Healthcare, Mexico City, Mexico.
4 Early Psychosis Intervention Department, Hospital Fray Bernardino Álvarez, Mexico City, Mexico; Palliative Care Unit, Instituto Nacional de Cancerología, Mexico City, Mexico.
5 Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
6 Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
7 Multimodal Neuroimaging Schizophrenia Group, Research Imaging Centre and Geriatric Mental Health Program, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Canada.
8 Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, USA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, USA.
9 Laboratory of Experimental Psychiatry, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico. Electronic address: [email protected].